United Kingdom· GB-APID-18244911000001101
VPRIV 400units powder for solution for infusion vials
A velaglucerase alfa product containing velaglucerase alfa, registered in United Kingdom by Takeda UK Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Velaglucerase alfa is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AB10 (velaglucerase alfa), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Velaglucerase alfa · ATC A16AB10
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Velaglucerase alfa
- Manufacturer
- Takeda UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- A16AB10
- ATC class
- Velaglucerase alfa
- Defined daily dose
- 300 E, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin7350006490095
- gtin05060147025965
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Velaglucerase alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandVprivShire Pharmaceuticals Ireland Ltd.
- CzechiaVPRIVTakeda Pharmaceuticals International AG Ireland Branch, Dublin
- SwedenVPRIV 200 E Pulver till infusionsvätska, lösningShire Pharmaceuticals Ireland Limited
- BelgiumVpriv 200 IUShire Pharmaceuticals Ireland
- FranceVPRIV 400 unités, poudre pour solution pour perfusionTAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- IrelandVPRIV 400 Units powder for solution for infusionShire Pharmaceuticals Ireland Limited
- IcelandVPRIVTakeda Pharmaceuticals International AG Ireland Branch
- Japanベラグルセラーゼ アルファ（遺伝子組換え）武田薬品工業
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vpriv
- Liechtenstein · Vpriv
- Norway · Vpriv
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cddec13b-de78-43e3-a874-5235adb59e6c GET /v1/drugs/cddec13b-de78-43e3-a874-5235adb59e6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "18244911000001101",
"desc": "VPRIV 400units powder for solution for infusion vials (Takeda UK Ltd)",
"form": "Powder for solution for infusion",
"vpid": "18244811000001106",
"source": "dmd",
"vtm_id": "777923004",
"strength": "400 unit",
"substance": "Velaglucerase alfa",
"ingredient": "Velaglucerase alfa",
"supplier_code": "3811601000001107"
}See everything about velaglucerase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.